These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7783664)

  • 1. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus.
    Yost TJ; Froyd KK; Jensen DR; Eckel RH
    Metabolism; 1995 Jun; 44(6):786-90. PubMed ID: 7783664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained weight reduction in moderately obese women results in decreased activity of skeletal muscle lipoprotein lipase.
    Eckel RH; Yost TJ; Jensen DR
    Eur J Clin Invest; 1995 Jun; 25(6):396-402. PubMed ID: 7656917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese non-insulin-dependent diabetes mellitus.
    Yost TJ; Sadur CN; Eckel RH
    Metabolism; 1995 Nov; 44(11):1475-80. PubMed ID: 7476337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans.
    Farese RV; Yost TJ; Eckel RH
    Metabolism; 1991 Feb; 40(2):214-6. PubMed ID: 1988780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
    Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
    Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects.
    Yost TJ; Jensen DR; Haugen BR; Eckel RH
    Am J Clin Nutr; 1998 Aug; 68(2):296-302. PubMed ID: 9701186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific responses of lipoprotein lipase to dietary macronutrient composition as a predictor of weight gain over 4 years.
    Ferland A; Château-Degat ML; Hernandez TL; Eckel RH
    Obesity (Silver Spring); 2012 May; 20(5):1006-11. PubMed ID: 22262159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation.
    Ferraro RT; Eckel RH; Larson DE; Fontvieille AM; Rising R; Jensen DR; Ravussin E
    J Clin Invest; 1993 Jul; 92(1):441-5. PubMed ID: 8326010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
    Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
    Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle lipase content and activity in obesity and type 2 diabetes.
    Jocken JW; Moro C; Goossens GH; Hansen D; Mairal A; Hesselink MK; Langin D; van Loon LJ; Blaak EE
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5449-53. PubMed ID: 20843949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.
    Klein HH; Vestergaard H; Kotzke G; Pedersen O
    Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    Simoneau JA; Kelley DE
    J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
    Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
    J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
    Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.